{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T05:47:23Z","timestamp":1696571243444},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T00:00:00Z","timestamp":1271894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. Math. Biol."],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s11538-010-9540-5","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T20:10:06Z","timestamp":1271880606000},"page":"230-247","source":"Crossref","is-referenced-by-count":9,"title":["Modeling Effect of a \u03b3-Secretase Inhibitor on Amyloid-\u03b2 Dynamics Reveals Significant Role of an Amyloid Clearance Mechanism"],"prefix":"10.1007","volume":"73","author":[{"given":"Raibatak","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Nachbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Edelstein-Keshet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansuman","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelynn J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,22]]},"reference":[{"key":"9540_CR1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1006\/bulm.2002.0304","volume":"64","author":"D.L. Craft","year":"2002","unstructured":"Craft, D.L., Wein, L.M., Selkoe, D.J., 2002. A mathematical model of the impact of novel treatments on the A beta burden in the Alzheimer\u2019s brain, CSF and plasma. Bull. Math. Biol. 64, 1011\u20131031.","journal-title":"Bull. Math. Biol."},{"key":"9540_CR2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R. Deane","year":"2003","unstructured":"Deane, R., Yan, S. Du, Submamaryan, R.K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., Zhu, H., Ghiso, J., Frangione, B., Stern, A., Schmidt, A.M., Armstrong, D.L., Arnold, B., Liliensiek, B., Nawroth, P., Hofman, F., Kindy, M., Stern, D., Zlokovic, B., 2003. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907\u2013913.","journal-title":"Nat. Med."},{"key":"9540_CR3","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"B. Efron","year":"1994","unstructured":"Efron, B., Tibshirani, R.J., 1994. An Introduction to the Bootstrap. Chapman and Hall, London."},{"key":"9540_CR4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.262.18.2551","volume":"262","author":"D.A. Evans","year":"1989","unstructured":"Evans, D.A., Funkenstein, H.H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., Hebert, L.E., Hennekens, C.H., Taylor, J.O., 1989. Prevalence of Alzheimer\u2019s disease in a community population of older persons. Higher than previously reported. J. Am. Med. Assoc. 262, 2551\u20132556.","journal-title":"J. Am. Med. Assoc."},{"key":"9540_CR5","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","volume":"279","author":"J. Ghiso","year":"2004","unstructured":"Ghiso, J., Shayo, M., Calero, M., Ng, D., Tomidokoro, Y., Gandy, S., Rostagno, A., Frangione, B., 2004. Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42. J. Biol. Chem. 279, 45897\u201345908.","journal-title":"J. Biol. Chem."},{"key":"9540_CR6","first-page":"53","volume":"42","author":"D.B. Gilberto","year":"2003","unstructured":"Gilberto, D.B., Zeoli, A.H., Szczerba, P.J., Gehret, J.R., Holahan, M.A., Sitko, G.R., Johnson, C.A., Cook, J.J., Motzel, S.L., 2003. An alternative method of chronic cerebrospinal fluid collection via the cisterna magna in conscious rhesus monkeys. Contemp. Top. Lab. Anim. Sci. 42, 53\u201359.","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"9540_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J. Hardy","year":"2002","unstructured":"Hardy, J., Selkoe, D.J., 2002. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356.","journal-title":"Science"},{"key":"9540_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"J.A. Hardy","year":"1992","unstructured":"Hardy, J.A., Higgins, G.A., 1992. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185.","journal-title":"Science"},{"key":"9540_CR9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.104.081901","volume":"313","author":"K.K. Kandimalla","year":"2005","unstructured":"Kandimalla, K.K., Curran, G.L., Holasek, S.S., Gilles, E.J., Wengenack, T.M., Poduslo, J.F., 2005. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer\u2019s disease transgenic mice (APP, PS1) and its implications for amyloid plaque formation. J. Pharmacol. Exp. Ther. 313, 1370\u20131378.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9540_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coph.2006.10.002","volume":"7","author":"J. Lundkvist","year":"2007","unstructured":"Lundkvist, J., Naslund, J., 2007. Gamma-secretase: a complex target for Alzheimer\u2019s disease. Curr. Opin. Pharmacol. 7, 112\u2013118.","journal-title":"Curr. Opin. Pharmacol."},{"key":"9540_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","volume":"38","author":"J.B. Mackic","year":"2002","unstructured":"Mackic, J.B., Bading, J., Ghiso, J., Walker, L., Wisniewski, T., Frangione, B., Zlokovic, B.V., 2002. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer\u2019s disease lesions. Vascul. Pharmacol. 38, 303\u2013313.","journal-title":"Vascul. Pharmacol."},{"key":"9540_CR12","unstructured":"Nachbar, R.B., Pak, I., Spann, A., 2006. Kinetic models in biology and chemistry. Wolfram Technology Conference. URL http:\/\/library.wolfram.com\/infocenter\/Conferences\/6463\/ ."},{"key":"9540_CR13","doi-asserted-by":"crossref","unstructured":"Rosen, L.B., Stone, J.A., Plump, A., Yuan, J., Harrison, T., Flynn, M., Dallob, A., Matthews, C., Stevenson, D., Schmidt, D., et\u00a0al., 2006. The gamma-secretase inhibitor mk-0752 acutely and significantly reduces csf ab40 concentrations in humans. In: 10th International Conference on Alzheimer\u2019s Disease and Related Disorders, Madrid. Abstract 04-03-02.","DOI":"10.1016\/j.jalz.2006.05.310"},{"key":"9540_CR14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"D.J. Selkoe","year":"2003","unstructured":"Selkoe, D.J., Schenk, D., 2003. Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545\u2013584.","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"9540_CR15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M. Shibata","year":"2000","unstructured":"Shibata, M., Yamada, S., Kumar, S.R., Calero, M., Bading, J., Frangione, B., Holtzman, D.M., Miller, C.A., Strickland, D.K., Ghiso, J., Zlokovic, B.V., 2000. Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489\u20131499.","journal-title":"J. Clin. Invest."},{"key":"9540_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.wnf.0000167360.27670.29","volume":"28","author":"E. Siemers","year":"2005","unstructured":"Siemers, E., Skinner, M., Dean, R.A., Gonzales, C., Satterwhite, J., Farlow, M., Ness, D., May, P.C., 2005. Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers. Clin. Neuropharmacol. 28, 126\u2013132.","journal-title":"Clin. Neuropharmacol."},{"key":"9540_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.WNL.0000198762.41312.E1","volume":"66","author":"E.R. Siemers","year":"2006","unstructured":"Siemers, E.R., Quinn, J.F., Kaye, J., Farlow, M.R., Porsteinsson, A., Tariot, P., Zoulnouni, P., Galvin, J.E., Holtzman, D.M., Knopman, D.S., Satterwhite, J., Gonzales, C., Dean, R.A., May, P.C., 2006. Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology 66, 602\u2013604.","journal-title":"Neurology"},{"key":"9540_CR18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C. Tamaki","year":"2006","unstructured":"Tamaki, C., Ohtsuki, S., Iwatsubo, T., Hashimoto, T., Yamada, K., Yabuki, C., Terasaki, T., 2006. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm. Res. 23, 1407\u20131416.","journal-title":"Pharm. Res."},{"key":"9540_CR19","first-page":"605","volume":"43","author":"R.E. Tanzi","year":"2004","unstructured":"Tanzi, R.E., Moir, R.D., Wagner, S.L., 2004. Clearance of Alzheimer\u2019s Abeta peptide: the many roads to perdition. Neuron 43, 605\u2013608.","journal-title":"Neuron"},{"key":"9540_CR20","doi-asserted-by":"crossref","first-page":"31499","DOI":"10.1074\/jbc.M112328200","volume":"277","author":"G. Tian","year":"2002","unstructured":"Tian, G., Sobotka-Briner, C.D., Zysk, J., Liu, X., Birr, C., Sylvester, M.A., Edwards, P.D., Scott, C.D., Greenberg, B.D., 2002. Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines. J. Biol. Chem. 277, 31499\u201331505.","journal-title":"J. Biol. Chem."},{"key":"9540_CR21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","volume":"89","author":"B.V. Zlokovic","year":"2004","unstructured":"Zlokovic, B.V., 2004. Clearing amyloid through the blood-brain barrier. J. Neurochem. 89, 807\u2013811.","journal-title":"J. Neurochem."},{"key":"9540_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/77397","volume":"6","author":"B.V. Zlokovic","year":"2000","unstructured":"Zlokovic, B.V., Yamada, S., Holtzman, D., Ghiso, J., Frangione, B., 2000. Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat. Med. 6, 718.","journal-title":"Nat. Med."}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-010-9540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11538-010-9540-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-010-9540-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T22:49:11Z","timestamp":1591224551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11538-010-9540-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["9540"],"URL":"https:\/\/doi.org\/10.1007\/s11538-010-9540-5","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,22]]}}}